Logo image of AMRB

American River Bkshs (AMRB) Stock Fundamental Analysis

USA - NASDAQ:AMRB -

20.91
+0.41 (+2%)
Last: 8/6/2021, 8:00:36 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMRB. AMRB was compared to 392 industry peers in the Banks industry. Both the profitability and financial health of AMRB have multiple concerns. AMRB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AMRB had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.9%
ROE 8.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMRB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 28.59%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

AMRB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

A Debt/Equity ratio of 0.15 indicates that AMRB is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.42% over the past year.
The Earnings Per Share has been growing by 11.38% on average over the past years. This is quite good.
The Revenue has grown by 13.10% in the past year. This is quite good.
Measured over the past years, AMRB shows a small growth in Revenue. The Revenue has been growing by 4.80% on average per year.
EPS 1Y (TTM)42.42%
EPS 3Y17.49%
EPS 5Y11.38%
EPS Q2Q%87.5%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y9.95%
Revenue growth 5Y4.8%
Sales Q2Q%16.31%

3.2 Future

Based on estimates for the next years, AMRB will show a decrease in Earnings Per Share. The EPS will decrease by -0.11% on average per year.
AMRB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.67% yearly.
EPS Next Y10.5%
EPS Next 2Y0.57%
EPS Next 3Y-0.15%
EPS Next 5Y-0.11%
Revenue Next Year10.99%
Revenue Next 2Y11.82%
Revenue Next 3Y5.53%
Revenue Next 5Y5.67%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AMRB Yearly Revenue VS EstimatesAMRB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
AMRB Yearly EPS VS EstimatesAMRB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.83, AMRB is valued correctly.
AMRB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
AMRB is valuated rather expensively with a Price/Forward Earnings ratio of 17.23.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, AMRB is valued a bit cheaper.
Industry RankSector Rank
PE 14.83
Fwd PE 17.23
AMRB Price Earnings VS Forward Price EarningsAMRB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMRB Per share dataAMRB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

AMRB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.41
PEG (5Y)1.3
EPS Next 2Y0.57%
EPS Next 3Y-0.15%

3

5. Dividend

5.1 Amount

AMRB has a Yearly Dividend Yield of 1.34%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.38, AMRB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.34%

5.2 History

On average, the dividend of AMRB grows each year by 8.78%, which is quite nice.
AMRB has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)8.78%
Div Incr YearsN/A
Div Non Decr YearsN/A
AMRB Yearly Dividends per shareAMRB Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y0.57%
EPS Next 3Y-0.15%

American River Bkshs

NASDAQ:AMRB (8/6/2021, 8:00:36 PM)

20.91

+0.41 (+2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.36%
Inst Owner Change0%
Ins Owners7.41%
Ins Owner Change0%
Market Cap125.04M
Analysts60
Price Target19.89 (-4.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.34%
Yearly Dividend0.28
Dividend Growth(5Y)8.78%
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.83
Fwd PE 17.23
P/S 4.32
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.41
EY6.74%
EPS(NY)1.21
Fwd EY5.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.84
BVpS15.53
TBVpSN/A
PEG (NY)1.41
PEG (5Y)1.3
Profitability
Industry RankSector Rank
ROA 0.9%
ROE 8.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 28.59%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.42%
EPS 3Y17.49%
EPS 5Y11.38%
EPS Q2Q%87.5%
EPS Next Y10.5%
EPS Next 2Y0.57%
EPS Next 3Y-0.15%
EPS Next 5Y-0.11%
Revenue 1Y (TTM)13.1%
Revenue growth 3Y9.95%
Revenue growth 5Y4.8%
Sales Q2Q%16.31%
Revenue Next Year10.99%
Revenue Next 2Y11.82%
Revenue Next 3Y5.53%
Revenue Next 5Y5.67%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A